Barrow Robert's Form 4 filing
Definium Therapeutics, Inc. (DFTX) · filed Jun 25, 2024
- Accession no.
- 0000950170-24-077495
- Filed
- Jun 25, 2024
- Trade date
- Jun 25, 2024
- Filing delay
- Same day
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $113.1K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Barrow RobertCIK 0001897557 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 25, 2024 | Common Shares | SSaleDisposed | −15,659 | $7.22 | −$113,057.98 | 564,543 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.